I-MAX LIGHTENING L description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

I-MAX LIGHTENING L

MAXLIFE USA, INC.

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert




FULL PRESCRIBING INFORMATION

Active ingredient

ACTIVE INGREDIENTS:
HYDROQUINONE USP 2%

Purpose

PURPOSE:

SKIN LIGHTENING

Uses

USES:

FOR THE GRADUAL FADING OF DARK AREAS OF THE SKIN.

WARNINGS:

AVOID CONTACT WITH EYES. SOME USERS MAY EXPERIENCE MILD SKIN IRRITATION.

IF IRRITATION BECOMES SEVERE, STOP USE AND CONSULT A DOCTOR.

THIS PRODUCT IS NOT INTENDED FOR USE IN THE PREVENTION OF SUNBURN AND CONTAINS AN ALPHA HYDROXY ACID (AHA) THAT MAY INCREASE YOUR SKIN'S SENSITIVITY TO THE SUN AND PARTICULARLY THE POSSIBILITY OF SUNBURN. SUN EXPOSURE SHOULD BE LIMITED BY USING A SUNSCREEN AGENT OR PROTECTIVE CLOTHING TO COVER BLEACHED SKIN AFTER TREATMENT IS COMPLETED TO PREVENT DARKENING FROM REOCCURING.

DIRECTIONS:

ADULTS: APPLY A SMALL AMOUNT AS A THIN LAYER ON THE AFFECTED AREA TWICE DAILY, OR USE AS DIRECTED BY A DOCTOR. IF NO IMPROVEMENT IS SEEN AFTER 3 MONTHS OF TREATMENT, USE OF THIS PRODUCT SHOULD BE DISCONTINUED. LIGHTENING EFFECT OF THIS PRODUCT MAY NOT BE NOTICEABLE WHEN USED ON VERY DARK SKIN.

CHILDREN UNDER 12 YEARS OF AGE: DO NOT USE UNLESS DIRECTED BY A DOCTOR.

INACTIVE INGREDIENTS:

ALPHA ARBUTIN, C13-14 ISOPARAFFIN, CETYL ALCOHOL, ETHYLHEXYLGLYCERIN, ETHYLHEXYL STEARATE, GLYCERIN, GLYCERYL STEARATE, GLYCOLIC ACID, ISOPROPYL MYRISTATE, LAURETH-7, NIACINAMIDE, PANTOTHENIC ACID, PEG-100 STEARATE, PHENOXYETHANOL, PHENYLETHYL RESORCINOL, POLYACRYLAMIDE, PYRIDOXINE HCL, SODIUM HYDROXIDE, SODIUM METABISULFITE, TETRAHEXYLDECYL ASCORBATE, WATER (AQUA), XANTHAN GUM.

QUESTIONS? 1-323-733-7033

KEEP OUT OF REACH OF CHILDREN.

I-MAX LIGHTENING L

HYDROQUINONE CREAM

Product Information

Product Type Human otc drug label Item Code (Source) NDC:42952-203
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Hydroquinone HYDROQUINONE 2 g

Inactive Ingredients

Ingredient Name Strength
C13-14 ISOPARAFFIN
CETYL ALCOHOL
ETHYLHEXYLGLYCERIN
ETHYLHEXYL STEARATE
GLYCERIN
GLYCERYL MONOSTEARATE
GLYCOLIC ACID
ISOPROPYL MYRISTATE
LAURETH-7
NIACINAMIDE
PANTOTHENIC ACID
PEG-100 STEARATE
PHENOXYETHANOL
POLYACRYLAMIDE (10000 MW)
PYRIDOXINE HYDROCHLORIDE
SODIUM HYDROXIDE
SODIUM METABISULFITE
TETRAHEXYLDECYL ASCORBATE
water
XANTHAN GUM
ALPHA-ARBUTIN
PHENYLETHYL RESORCINOL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:42952-203-12 59 in 1 TUBE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
partA part358A 2012-09-18


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.